Critical Therapeutics Inc (NASDAQ:CRTX) will release the fourth quarter earnings for 2007 on March 3.
A biopharmaceutical company, Critical Therapeutics focuses on the discovery, development and commercialization of products to treat respiratory, inflammatory and critical care diseases through the regulation of the body’s inflammatory response.
Collaborating with MedImmune Inc, the company is developing monoclonal antibodies directed towards HMGB1.
For more
Earnings related events or to post your own events, visit: